1. Amelioration of Single Clove Black Garlic Aqueous Extract on Dyslipidemia and Hepatitis in Chronic Carbon Tetrachloride Intoxicated Swiss Albino Mice
   Gia-Buu Tran et al, 2018, International Journal of Hepatology CrossRef
2. Anti‑fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC‑T6 cells
   Yan Li et al, 2018, Experimental and Therapeutic Medicine CrossRef
3. New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
   Abdallah E Abdallah et al, 2022, Drug Design, Development and Therapy CrossRef
4. 20-Hydroxytetraenoic acid induces hepatic fibrosis via the TGF-β1/Smad3 signaling pathway
   Biao Li et al, 2023, Toxicology Letters CrossRef
5. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
   Ying Wu et al, 2023, World Journal of Gastroenterology CrossRef
6. Therapy that Targets Growth Factor Receptors: Novel Approach for Liver Cirrhosis Treatment
   Halyna Kuznietsova et al, 2021, Advances in Hepatology CrossRef
7. Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities
   Mohamed E. Shaker et al, 2023, International Immunopharmacology CrossRef
8. New fluorinated diarylureas linked to pyrrolo[2,3-d]pyrimidine scaffold as VEGFR-2 inhibitors: Molecular docking and biological evaluation
   Mai Adel et al, 2022, Bioorganic Chemistry CrossRef
9. Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis
   Ying Wu et al, 2022, BioMed Research International CrossRef
10. Effect of Curcumol on the Fenestrae of Liver Sinusoidal Endothelial Cells Based on NF-κB Signaling Pathway
    Yang Zheng et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
11. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease
    Emilie K. Mitten et al, 2022, Journal of Hepatology CrossRef
12. Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms
    Heming Ma et al, 2021, Molecular Biology Reports CrossRef
13. Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
    Si-Nan Lin et al, 2022, Physiological Reviews CrossRef
14. Therapeutic molecular targets of SSc-ILD
    Yun Zhang et al, 2020, Journal of Scleroderma and Related Disorders CrossRef
15. Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis
    Hiroyuki Ogawa et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
16. Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation
    Abdallah E. Abdallah et al, 2021, Bioorganic Chemistry CrossRef
17. Met/HGFR triggers detrimental reactive microglia in TBI
    Rida Rehman et al, 2022, Cell Reports CrossRef
18. Actin Depolymerization in Dedifferentiated Liver Sinusoidal Endothelial Cells Promotes Fenestrae Re‐Formation
    Julie Di Martino et al, 2019, Hepatology Communications CrossRef
19. Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
    Abdallah E. Abdallah et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
20. Two cases of benign hepatic nodules caused by sinusoidal dilatation with different hemodynamics
    Hiroya Iida et al, 2020, Clinical Journal of Gastroenterology CrossRef
21. The Provocative Roles of Platelets in Liver Disease and Cancer
    Preeti Kanikarla Marie et al, 2021, Frontiers in Oncology CrossRef
22. Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
    Qiying Pei et al, 2023, International Journal of Molecular Sciences CrossRef